|
|
|
||
BMJ
1999;319:290-291 ( 31 July )
PapersAccuracy of perceptions of hepatitis B and C status: cross sectional investigation of opiate addicts in treatmentDavid Best National Addiction Centre, The Maudsley Hospital and Institute of
Psychiatry, London SE5 8AF
Correspondence to: D Best d.best@iop.kcl.ac.uk
Infection with hepatitis C and hepatitis B viruses is common among
injecting drug users.1-4 In a sample of
blood donors only 0.01% were positive for antibodies to
hepatitis C virus,5 whereas 59%
of injecting drug users in East Anglia were positive, with 22%
also positive for hepatitis B virus.2
Rhodes et al reported that about half (58% in 1992 and
50% in 1993) of those whose salivary specimens contained
antibodies to hepatitis B virus were unaware of their
infection.4 Although drug users are
generally aware of the risks of infection, their awareness
of their own status is uncertain. We tested opiate addicts
receiving methadone maintenance treatment for markers of
hepatitis B and hepatitis C infection and compared the
results with their beliefs about their viral status. We collected data on 106 injecting opiate addicts attending a methadone maintenance clinic in London. Sufficient blood was obtained for 90 hepatitis C virus tests and for 84 hepatitis B virus tests (when blood was insufficient, priority was given to hepatitis C). We present data for the 90 addicts from whom blood was obtained. The participants' mean age was 36 years (range 21-54), and 69 were men. They had attended the clinic for an average of 2.4 years and received a mean methadone dose of 72 mg (range 15-150 mg). Their mean age at first opiate injection was 21, and the mean duration of injecting was 15 years. Fifty nine had used a syringe after someone else, and 68 had shared injecting paraphernalia. Seventy seven were positive for hepatitis C virus, and 46 were positive for hepatitis B virus. Of the 79 who reported having previously been tested for hepatitis C virus, 58 thought they were positive, 16 thought they were negative (of whom half were wrong), and five were uncertain. Of the 70 addicts previously tested for hepatitis C virus whom we found to be positive, 12 did not know or were wrong about their status (see table). Of the 41 previously tested for hepatitis B virus whom we found to be positive, 16 thought themselves to be negative.
Of the 11 addicts never previously tested for hepatitis C virus, four were correct in their self assessment (one positive, three negative), four incorrectly thought they were negative, and three did not know. Of the 22 addicts not previously tested for hepatitis B virus, six were correct in their self assessment (all negative), while three mistakenly believed they were positive and one negative, and 12 could not report their viral status (five positive, seven negative). Subjects never previously tested for hepatitis B virus were less
likely to be seropositive (5/22 v 41/62; Our finding of 86% seropositivity for hepatitis C virus is
consistent with the 67% found among Australian injecting drug users1
and 75% among UK addicts receiving maintenance treatment.3
The participants' perceptions of their viral status were often
inaccurate: for both hepatitis B and hepatitis C virus, they
tended to believe they were negative when they were
positive. If untested drug users assume they are positive
and act accordingly they pose no threat to public health.
If they mistakenly presume negative status, this may have
serious public health consequences. Clinicians should
encourage testing in all patients who are injecting drug users
and use this as a catalyst for interventions. As Crofts et
al point out,1 drug treatment alone is
not sufficient in reducing hepatitis seroconversion and
clinicians must be more vigorous in encouraging drug users
to reduce risk behaviours. We thank the staff and patients involved in the study. Contributors: JS, DB, and EF conceived and initiated the study,
for which the data were then collected by DB, EF, AN, and CS. All
authors contributed to the analysis and preparation of the article.
DB, EF, and JS are guarantors for the study. Footnotes Funding: No specific funding. All the authors are employees of the Institute of Psychiatry or Bethlem and Maudsley NHS Trust. Their research work is also supported by the charity Action on Addiction. Competing interests: None declared.
(Accepted 18 February 1999)
|
2=10.66,
df=1, P<0.005). A similar pattern was seen for hepatitis C
virus positivity (7/11 v 70/79; 